Manipulation of PBF/PTTG1IP phosphorylation status; a potential new therapeutic strategy for improving radioiodine uptake in thyroid and other tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 7, 2013, Pages 2876-2886

  Smith, V E ^a   Sharma, N ^a   Watkins, R J ^a   Read, M L ^a   Ryan, G A ^a   Kwan, P P ^a   Martin, A ^a   Watkinson, J C ^a   Boelaert, K ^a   Franklyn, J A ^a   McCabe, Chris ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; GLUTATHIONE TRANSFERASE; PHOSPHOPROTEIN; PITUITARY TUMOR TRANSFORMING GENE BINDING FACTOR; PROTEIN TYROSINE KINASE; RADIOACTIVE IODINE; SODIUM IODIDE SYMPORTER; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL CULTURE; CELL MEMBRANE; CELLULAR DISTRIBUTION; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG UPTAKE; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; IN VITRO STUDY; MASS SPECTROMETRY; MULTIPLE CANCER; MUTATION; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; THYROID CARCINOMA; UTERINE CERVIX CARCINOMA;

AMINO ACID SUBSTITUTION; ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL MEMBRANE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; HUMANS; IODINE RADIOISOTOPES; MEMBRANE PROTEINS; MUTANT PROTEINS; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RADIOPHARMACEUTICALS; RECOMBINANT PROTEINS; SYMPORTERS; THYROID GLAND; THYROID NEOPLASMS;

EID: 84879991652     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-3640     Document Type: Article

References (25)

1. Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature. 1996;379:458-460. (Pubitemid 26039527)
2. Smanik PA, Liu Q, Furminger TL, et al. Cloning of the human sodium iodide symporter. Biochem Biophys Res Commun. 1996;226:339-345. (Pubitemid 26331906)
3. Kogai T, Taki K, Brent GA. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. Endocr Relat Cancer. 2006;13:797-826. (Pubitemid 44763258)
4. Castro MR, Bergert ER, Beito TG, et al. Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancer. J Endocrinol. 1999;163:495-504. (Pubitemid 30033745)
5. - symporter (NIS) in a large sampling of thyroid cancer cases. J Clin Endocrinol Metab. 2001;86:2697-2700.
6. Wapnir IL, van de Rijn M, Nowels K, et al. Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections. J Clin Endocrinol Metab. 2003;88:1880-1888. (Pubitemid 36623418)
7. Tazebay UH, Wapnir IL, Levy O, et al. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med. 2000;6:871-878. (Pubitemid 30644744)
8. Riesco-Eizaguirre G, Santisteban P. A perspective view of sodium iodide symporter research and its clinical implications. Eur J Endocrinol. 2006;155:495-512. (Pubitemid 44608424)
9. Yaspo ML, Aaltonen J, Horelli-Kuitunen N, Peltonen L, Lehrach H. Cloning of a novel human putative type Ia integral membrane protein mapping to 21q22.3. Genomics. 1998;49:133-136. (Pubitemid 28194446)
10. Stratford AL, Boelaert K, Tannahill LA, et al. Pituitary tumor transforming gene binding factor: a novel transforming gene in thyroid tumorigenesis. J Clin Endocrinol Metab. 2005;90:4341-4349. (Pubitemid 41058217)
11. Watkins RJ, Read ML, Smith VE, et al. Pituitary tumor transforming gene binding factor: a new gene in breast cancer. Cancer Res. 2010;70:3739-3749.
12. Boelaert K, McCabe CJ, Tannahill LA, et al. Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancer. J Clin Endocrinol Metab. 2003;88:2341-2347. (Pubitemid 36549916)
13. Hsueh C, Lin JD, Chang YS, et al. Prognostic significance of pituitary tumour-transforming gene-binding factor (PBF) expression in papillary thyroid carcinoma. Clin Endocrinol (Oxf). 2013;78:303-309.
14. Boelaert K, Smith VE, Stratford AL, et al. PTTG and PBF repress the human sodium iodide symporter. Oncogene. 2007;26:4344-4356. (Pubitemid 47014460)
15. Smith VE, Read ML, Turnell AS, et al. A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer. J Cell Sci. 2009;122:3393-3402.
16. Read ML, Lewy GD, Fong JC, et al. Proto-oncogene PBF/PTTG1IP regulates thyroid cell growth and represses radioiodide treatment. Cancer Res. 2011;71:6153-6164.
17. Smith VE, Read ML, Turnell AS, et al. PTTG-binding factor (PBF) is a novel regulator of the thyroid hormone transporter MCT8. Endocrinology. 2012;153:3526-3536.
18. Kogai T, Brent GA. The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics. Pharmacol Ther. 2012;135:355-370.
19. Eggo MC, King WJ, Black EG, Sheppard MC. Functional human thyroid cells and their insulin-like growth factor-binding proteins: regulation by thyrotropin, cyclic 3′,5′ adenosine monophosphate, and growth factors. J Clin Endocrinol Metab. 1996;81:3056-3062. (Pubitemid 26323908)
20. Ambesi-Impiombato FS, Parks LA, Coon HG. Culture of hormone-dependent functional epithelial cells from rat thyroids. Proc Natl Acad Sci USA. 1980;77:3455-3459. (Pubitemid 10012253)
21. Hornbeck PV, Kornhauser JM, Tkachev S, et al. PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res. 2012;40:D261-D270.
22. Ohno H, Fournier MC, Poy G, Bonifacino JS. Structural determinants of interaction of tyrosine-based sorting signals with the adaptor medium chains. J Biol Chem. 1996;271:29009-29015. (Pubitemid 26382605)
23. Schweppe RE, Kerege AA, French JD, Sharma V, Grzywa RL, Haugen BR. Inhibition of Src with AZD0530 reveals the Src-Focal Adhesion kinase complex as a novel therapeutic target in papillary and anaplastic thyroid cancer. J Clin Endocrinol Metab. 2009;94:2199-2203.
24. Di Cosmo C, Liao XH, Dumitrescu AM, Philp NJ, Weiss RE, Refetoff S. Mice deficient inMCT8reveal a mechanism regulating thyroid hormone secretion. J Clin Invest. 2010;120:3377-3388.
25. Trajkovic-Arsic M, Müller J, Darras VM, et al. Impact of monocarboxylate transporter-8 deficiency on the hypothalamus-pituitary-thyroid axis in mice. Endocrinology. 2010;151:5053-5062.